FITC-labeled ODN 1668 (sodium), a class B CpG oligodeoxynucleotide (ODN), functions as a TLR9 agonist. This compound is utilized to assess the cellular uptake and localization of CpG ODNs using techniques such as confocal laser-scanning microscopy (excitation 495 nm, emission 520 nm) and flow cytometry.